Guangdong Provincial People's Hospital: Carcinoma, Non-Small-Cell Lung trials

The registry lists 17 Carcinoma, Non-Small-Cell Lung studies with Guangdong Provincial People's Hospital as lead sponsor. 8 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 11Phase 3 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Local Consolidative Therapy Versus Maintenance Immunotherapy After First-Line Chemoimmunotherapy in Metastatic NSCLCNot yet recruitingNCT07842471Phase 2
• Microbiota in Neoadjuvant Chemoimmunotherapy for NSCLCNot yet recruitingNCT07752589
• Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)RecruitingNCT07472478Phase 2
• D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLCRecruitingNCT07016126Phase 3
• MRNA Neoantigen Vaccine in Non-Small Cell Lung CancerNot yet recruitingNCT06735508Early Phase 1
• Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung CancerRecruitingNCT06734182Phase 2
• Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLCRecruitingNCT05800340Phase 2
• Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving SurgeryRecruitingNCT05648370
• Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLCActive, not recruitingNCT06300424Phase 2
• Induction Lorlatinib in Stage III Non-small Cell Lung CancerActive, not recruitingNCT05740943Phase 2
• Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLCCompletedNCT05637580
• Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLCActive, not recruitingNCT05244213Phase 2
• Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLCStatus unknownNCT04984148
• Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLCStatus unknownNCT03074864Phase 2/3
• Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung CancerStatus unknownNCT00663689Phase 2
• Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung CancerStatus unknownNCT00614809Phase 2
• Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00600587Phase 2